help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grunfeld, C.
Right arrow Articles by Feingold, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grunfeld, C.
Right arrow Articles by Feingold, K. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*AIDS

Journal of Clinical Endocrinology & Metabolism, Vol 74, 1045-1052, Copyright © 1992 by Endocrine Society

ARTICLES

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

C Grunfeld, M Pang, W Doerrler, JK Shigenaga, P Jensen and KR Feingold
Department of Medicine, University of California, San Francisco.

Infection causes disturbances in lipid metabolism that may be mediated by cytokines. Therefore we studied plasma lipids, lipoproteins, triglyceride (TG) metabolism, and serum cytokines in three groups: patients with the acquired immunodeficiency syndrome (AIDS) without active secondary infection, patients with evidence of human immunodeficiency virus infection but without clinical AIDS (HIV+), and controls. Plasma TGs and FFA were increased in AIDS, while plasma cholesterol, high density lipoprotein (HDL) cholesterol, apolipoprotein- A-1 (Apo-A-1), low density lipoprotein (LDL) cholesterol, and Apo-B-100 levels were decreased. Increased TG levels in AIDS were primarily due to increases in very low density lipoprotein of normal composition; in addition, LDL and HDL were TG enriched. In HIV+, TGs and FFA were not increased, but total cholesterol, HDL cholesterol, Apo-A-1, and Apo-B- 100 were significantly decreased. Interferon-alpha (IFN alpha) and C- reactive protein levels were increased in AIDS, but tumor necrosis factor and haptoglobin levels were not. There was a significant correlation between plasma TGs and IFN alpha levels (r = 0.477; P less than 0.01), but not between TGs and tumor necrosis factor, C-reactive protein, haptoglobin, or P-24 antigen. In addition, there was no relationship between circulating IFN alpha levels and plasma cholesterol, HDL cholesterol, Apo-A-1, LDL cholesterol, Apo-B-100, or FFA. TG clearance time and postheparin lipase were significantly decreased in AIDS and HIV+. There was a strong correlation between serum IFN alpha levels and TG clearance time in AIDS and HIV+ (r = 0.783; P less than 0.001). In summary, decreases in cholesterol and cholesterol containing lipoproteins (including HDL) in both AIDS and HIV+ precede the appearance of hypertriglyceridemia and are not related to IFN alpha or TG levels. Our data raise the possibility that with development of AIDS, subsequent increases in IFN alpha may contribute to increases in plasma TG levels in part by decreasing the clearance of TG.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
T. T. Brown
Approach to the Human Immunodeficiency Virus-Infected Patient with Lipodystrophy
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2937 - 2945.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Schillaci, G. V.L. De Socio, G. Pucci, M. R. Mannarino, J. Helou, M. Pirro, and E. Mannarino
Aortic Stiffness in Untreated Adult Patients With Human Immunodeficiency Virus Infection
Hypertension, August 1, 2008; 52(2): 308 - 313.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Schambelan, P. W.F. Wilson, K. E. Yarasheski, W. T. Cade, V. G. Davila-Roman, R. B. D'Agostino Sr, T. A. Helmy, M. Law, K. E. Mondy, S. Nachman, et al.
Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients
Circulation, July 8, 2008; 118(2): e48 - e53.
[Full Text] [PDF]

Home page
 CirculationHome page
J. H. Stein, C. M. Hadigan, T. T. Brown, E. Chadwick, J. Feinberg, N. Friis-Moller, A. Ganesan, M. J. Glesby, D. Hardy, R. C. Kaplan, et al.
Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients
Circulation, July 8, 2008; 118(2): e54 - e60.
[Full Text] [PDF]

Home page
 CirculationHome page
C. Grunfeld, D. P. Kotler, D. K. Arnett, J. M. Falutz, S. M. Haffner, P. Hruz, H. Masur, J. B. Meigs, K. Mulligan, P. Reiss, et al.
Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors
Circulation, July 8, 2008; 118(2): e20 - e28.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Kline, D. J. Kleinhenz, B. Liang, S. Dikalov, D. M. Guidot, C. M. Hart, D. P. Jones, and R. L. Sutliff
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2792 - H2804.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
A. S Wierzbicki, S. D Purdon, T. C Hardman, R. Kulasegaram, and B. S Peters
Review: Clinical aspects of the management of HIV lipodystrophy
The British Journal of Diabetes & Vascular Disease, May 1, 2008; 8(3): 113 - 119.
[Abstract] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Bongiovanni, M. Casana, P. Cicconi, M. Pisacreta, R. Codemo, M. Pelucchi, A. d'Arminio Monforte, and T. Bini
Predictive factors of vascular intima media thickness in HIV-positive subjects
J. Antimicrob. Chemother., January 1, 2008; 61(1): 195 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. C. Odden, R. Scherzer, P. Bacchetti, L. A. Szczech, S. Sidney, C. Grunfeld, and M. G. Shlipak
Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus Infection: The FRAM Study
Arch Intern Med, November 12, 2007; 167(20): 2213 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. A. Triant, H. Lee, C. Hadigan, and S. K. Grinspoon
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2506 - 2512.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
The DAD Study Group
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
N. Engl. J. Med., April 26, 2007; 356(17): 1723 - 1735.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Popa, M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef
The role of TNF-{alpha} in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
J. Lipid Res., April 1, 2007; 48(4): 751 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. Chen, W. Li, N. Wang, Y. Zhu, and X. Wang
ROS and NF-{kappa}B but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1493 - C1501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Balasubramanyam, H. Mersmann, F. Jahoor, T. M. Phillips, R. V. Sekhar, U. Schubert, B. Brar, D. Iyer, E. O. Smith, H. Takahashi, et al.
Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E40 - E48.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Hadigan, J. Liebau, M. Torriani, R. Andersen, and S. Grinspoon
Improved Triglycerides and Insulin Sensitivity with 3 Months of Acipimox in Human Immunodeficiency Virus-infected Patients with Hypertriglyceridemia
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4438 - 4444.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. Lu, A. H. Moser, J. K. Shigenaga, K. R. Feingold, and C. Grunfeld
Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response
J. Lipid Res., October 1, 2006; 47(10): 2179 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. E. Dolan, W. Frontera, J. Librizzi, K. Ljungquist, S. Juan, R. Dorman, M. E. Cole, J. R. Kanter, and S. Grinspoon
Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial.
Arch Intern Med, June 12, 2006; 166(11): 1225 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
P. C. Tien, C. Benson, A. R. Zolopa, S. Sidney, D. Osmond, C. Grunfeld, and for the FRAM Study Investigators
The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): Methods, Design, and Sample Characteristics
Am. J. Epidemiol., May 1, 2006; 163(9): 860 - 869.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Y. Hsue and D. D. Waters
What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection
Circulation, December 20, 2005; 112(25): 3947 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
C. Wanke, J. Gerrior, K. Hendricks, J. McNamara, and E. Schaefer
Alterations in Lipid Profiles in HIV-Infected Patients Treated With Protease Inhibitor Therapy Are Not Influenced by Diet
Nutr Clin Pract, December 1, 2005; 20(6): 668 - 673.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y. Wang, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold
Downregulation of liver X receptor-{alpha} in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines
J. Lipid Res., November 1, 2005; 46(11): 2377 - 2387.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Thomas-Geevarghese, S. Raghavan, R. Minolfo, S. Holleran, R. Ramakrishnan, B. Ormsby, W. Karmally, H. N Ginsberg, W. M El-Sadr, J. Albu, et al.
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 146 - 154.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Margeli, K. Skenderi, M. Tsironi, E. Hantzi, A.-L. Matalas, C. Vrettou, E. Kanavakis, G. Chrousos, and I. Papassotiriou
Dramatic Elevations of Interleukin-6 and Acute-Phase Reactants in Athletes Participating in the Ultradistance Foot Race Spartathlon: Severe Systemic Inflammation and Lipid and Lipoprotein Changes in Protracted Exercise
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3914 - 3918.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Shahmanesh, S. Das, M. Stolinski, F. Shojaee-Moradie, N. C. Jackson, W. Jefferson, R. Cramb, P. Nightingale, and A. M. Umpleby
Antiretroviral Treatment Reduces Very-Low-Density Lipoprotein and Intermediate-Density Lipoprotein Apolipoprotein B Fractional Catabolic Rate in Human Immunodeficiency Virus-Infected Patients with Mild Dyslipidemia
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 755 - 760.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. H. Stein, M. A. Merwood, J. B. Bellehumeur, P. E. McBride, D. A. Wiebe, and J. M. Sosman
Postprandial Lipoprotein Changes in Patients Taking Antiretroviral Therapy for HIV Infection
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 399 - 405.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Grinspoon and A. Carr
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
N. Engl. J. Med., January 6, 2005; 352(1): 48 - 62.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kojma, K.-i. Hirata, T. Ishida, Y. Shimokawa, N. Inoue, S. Kawashima, T. Quertermous, and M. Yokoyama
Endothelial Lipase Modulates Monocyte Adhesion to the Vessel Wall: A POTENTIAL ROLE IN INFLAMMATION
J. Biol. Chem., December 24, 2004; 279(52): 54032 - 54038.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Y. Hsue, J. C. Lo, A. Franklin, A. F. Bolger, J. N. Martin, S. G. Deeks, and D. D. Waters
Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection
Circulation, April 6, 2004; 109(13): 1603 - 1608.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Johnson, J. B. Albu, E. S. Engelson, S. K. Fried, Y. Inada, G. Ionescu, and D. P. Kotler
Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E261 - E271.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L. Calza, R. Manfredi, and F. Chiodo
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients
J. Antimicrob. Chemother., January 1, 2004; 53(1): 10 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Yarasheski, P. Tebas, S. Claxton, D. Marin, T. Coleman, W. G. Powderly, and C. F. Semenkovich
Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E899 - E905.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. M. Petit, M. Duong, E. Florentin, L. Duvillard, P. Chavanet, J. M. Brun, H. Portier, P. Gambert, and B. Verges
Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study
J. Lipid Res., September 1, 2003; 44(9): 1692 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. P. Erlinger, E. R. Miller III, J. Charleston, and L. J. Appel
Inflammation Modifies the Effects of a Reduced-Fat Low-Cholesterol Diet on Lipids: Results From the DASH-Sodium Trial
Circulation, July 15, 2003; 108(2): 150 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
F. Jahoor, S. Abramson, and W. C Heird
The protein metabolic response to HIV infection in young children
Am. J. Clinical Nutrition, July 1, 2003; 78(1): 182 - 189.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. A. Riddler, E. Smit, S. R. Cole, R. Li, J. S. Chmiel, A. Dobs, F. Palella, B. Visscher, R. Evans, and L. A. Kingsley
Impact of HIV Infection and HAART on Serum Lipids in Men
JAMA, June 11, 2003; 289(22): 2978 - 2982.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. S. Kim, J. Shigenaga, A. Moser, K. Feingold, and C. Grunfeld
Repression of Farnesoid X Receptor during the Acute Phase Response
J. Biol. Chem., March 7, 2003; 278(11): 8988 - 8995.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. A. Bozzette, C. F. Ake, H. K. Tam, S. W. Chang, and T. A. Louis
Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
N. Engl. J. Med., February 20, 2003; 348(8): 702 - 710.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Chen, A. Misra, and A. Garg
Lipodystrophy in Human Immunodeficiency Virus-Infected Patients
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4845 - 4856.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
T. M. Riddle, N. M. Schildmeyer, C. Phan, C. J. Fichtenbaum, and D. Y. Hui
The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice
J. Lipid Res., September 1, 2002; 43(9): 1458 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. V. Sekhar, F. Jahoor, A. C. White, H. J. Pownall, F. Visnegarwala, M. C. Rodriguez-Barradas, M. Sharma, P. J. Reeds, and A. Balasubramanyam
Metabolic basis of HIV-lipodystrophy syndrome
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E332 - E337.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
F. Picard, D. Arsenijevic, D. Richard, and Y. Deshaies
Responses of Adipose and Muscle Lipoprotein Lipase to Chronic Infection and Subsequent Acute Lipopolysaccharide Challenge
Clin. Vaccine Immunol., July 1, 2002; 9(4): 771 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. A. Panther
How HIV infection and its treatment affects the cardiovascular system: what is known, what is needed
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H1 - H4.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
N M Vink, A M C van Rossum, N G Hartwig, R de Groot, and S Geelen
Lipid and glucose metabolism in HIV-1-infected children treated with protease inhibitors
Arch. Dis. Child., January 1, 2002; 86(1): 67 - 67.
[Full Text] [PDF]

Home page
 CirculationHome page
J. H. Stein, M. A. Klein, J. L. Bellehumeur, P. E. McBride, D. A. Wiebe, J. D. Otvos, and J. M. Sosman
Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction
Circulation, July 17, 2001; 104(3): 257 - 262.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Hadigan, C. Corcoran, T. Stanley, S. Piecuch, A. Klibanski, and S. Grinspoon
Fasting Hyperinsulinemia in Human Immunodeficiency Virus-Infected Men: Relationship to Body Composition, Gonadal Function, and Protease Inhibitor Use
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 35 - 41.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Hadigan, K. Miller, C. Corcoran, E. Anderson, N. Basgoz, and S. Grinspoon
Fasting Hyperinsulinemia and Changes in Regional Body Composition in Human Immunodeficiency Virus-Infected Women
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1932 - 1937.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Jahoor, B. Gazzard, G. Phillips, D. Sharpstone, M. Delrosario, M. E. Frazer, W. Heird, R. Smith, and A. Jackson
The acute-phase protein response to human immunodeficiency virus infection in human subjects
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1092 - E1098.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Grunfeld, W. Doerrler, M. Pang, P. Jensen, K. H. Weisgraber, and K. R. Feingold
Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3734 - 3740.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society